Food & Health

Laboratory technician using pipette in a lab with Novo Nordisk branding.

The European Medicines Agency has endorsed approval for Novo Nordisk’s oral Wegovy formulation, establishing a pathway for Europe’s inaugural oral weight-loss medication and positioning the company ahead of competitor Eli Lilly. This achievement may broaden treatment...

A healthcare professional discussing with a patient.

Eli Lilly's Retatrutide Elevates Weight-Loss Standards

Eli Lilly’s (LLY) investigational obesity treatment achieved weight reductions of up to 28% in...

Wendy's Q1 Upsurge: A Turnaround in Motion

Wendy’s (WEN) reported increased first-quarter revenue as the fast-food operator continues efforts to revive sales growth at domestic locations...

Eli Lilly's Foundayo Sees Strong Early Demand

General Mills Stands Firm Amid Demand Challenges

Regenxbio's Breakthrough in Duchenne Gene Therapy

Fresh $3 & $4 Deals at McDonald's: Value Menu Insights

Leucovorin Gains FDA Nod for Rare Brain Disorder

universal-health-to-acquire-talkspace-for-835-million-in-men-1773074124679

Universal Health, Talkspace Join Forces in $835M Deal

2 months ago

Universal Health Services (UHS.N) agreed to acquire virtual mental health provider Talkspace (TALK.O) for $835 million, sending shares up more than 7% as the hospital operator...

pfizer-s-eczema-drug-hits-mid-stage-trial-goal-advances-to-p-1773074221144

Pfizer's Eczema Breakthrough: Tilrekimig Moves to Phase 3

2 months ago

Pfizer (PFE.N) said its experimental eczema drug tilrekimig met the main goal in a mid-stage trial, sending shares up marginally as the drugmaker plans late-stage testing this...

gsk-sells-liver-disease-drug-rights-to-alfasigma-for-up-to-6-1773074327402

GSK Transfers Liver Drug Rights to Alfasigma - TMT

2 months ago

GlaxoSmithKline (GSK.L) agreed to sell global rights to its experimental liver disease drug linerixibat to Italy’s Alfasigma for up to $690 million, as the British drugmaker...

johnson-johnson-launches-direct-to-consumer-drug-sales-platf-1772668476990

J&J's Direct Drug Sales: A Bold Move Unveiled

2 months ago

Johnson & Johnson (JNJ) launched a website to sell drugs directly to U.S. consumers without insurance coverage, mirroring strategies from competitors like Pfizer and Eli Lilly1. The...

GSK's Hepatitis B Drug Meets Primary Goals in Phase III Trials

4 months ago

GSK (GSK.L) announced its experimental hepatitis B treatment bepirovirsen met primary endpoints in two phase III studies, advancing regulatory filing plans. The positive results...

Food & Health

Universal Health, Talkspace Join Forces in $835M Deal

Pfizer's Eczema Breakthrough: Tilrekimig Moves to Phase 3

GSK Transfers Liver Drug Rights to Alfasigma - TMT

J&J's Direct Drug Sales: A Bold Move Unveiled

GSK's Hepatitis B Drug Meets Primary Goals in Phase III Trials

MORE NEWS

Incyte Blood Cancer Drug Meets Key Trial Goal, Shares Rise 2.3%

Novo Nordisk Launches Wegovy Weight-Loss Pill at 149 Monthly for Self-Pay Patients

Drugmakers Raise Prices on 350 Medicines Despite Trump Pressure

CATEGORIES